Researcher

My research project is about tackling challenges arising in the characterization of new antibody formats as well as of new therapy forms such as gene therapy. Recently I’m working on the development of a multidimensional LC platform for the fast and automated characterization of AAV variants and their capsid proteins. Next to that I focus on the development of CESI-MS methods for the functional characterization of biopharmaceuticals and their affinity receptors.
Dr. Christoph Gstöttner obtained his Ph.D. in 2021 at the Leiden University Medical Center (Netherlands) under the supervision of Prof. M. Wuhrer. His Ph.D. research was focused on the development of electrophoretic but also chromatographic methodologies for the in-depth analysis of biopharmaceuticals such as monoclonal antibodies or newer antibody formats. Before that he worked for 1.5 years in the biopharmaceutical industry, where he also completed his master thesis on the development of an automated platform for the characterization of monoclonal antibodies.
Christoph Gstöttner, Michaela Hook, Tony Christopeit, Alexander Knaupp, Tilman Schlothauer, Dietmar Reusch, Markus Haberger, Manfred Wuhrer, Elena Domínguez-Vega
Analytical Chemistry, 2021, 93, 45, 15133–15141, doi.org/10.1021/acs.analchem.1c03560
Sanne Pot, Christoph Gstöttner, Katrin Heinrich, Sina Hoelterhoff, Ingrid Grunert, Michael Leiss, Anja Bathke, Elena Domínguez-Vega
Analytica Chimica Acta, 2021, Volume 1184, 339015, doi.org/10.1016/j.aca.2021.339015
Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega
Analytical Chemistry, 2021, 93, 17, 6839–6847, doi.org/10.1021/acs.analchem.1c00893
If you'd like to collaborate with us, you are welcome to send us a message!